Normal view MARC view ISBD view

Application of existing technology to meet increasing demands for automated sample handling. [electronic resource]

By:

Chow, A T

Contributor(s):

Producer: 19901102Description: 1579-82 p. digitalISSN:

0009-9147

Subject(s):

In: Clinical chemistry vol. 36

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

121 Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial.
by Singh, Jagdeep S S
122 Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.
by Ferreira, João Pedro
123 Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF.
by Kobayashi, Masatake
124 Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study.
by Lombardi, Carlo Mario
125 Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis.
by Du, Heyue
126 Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.
by Cameron, Amy R
127 Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
by O'Meara, Eileen
128 The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
by Taylor, Rod S
129 Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors.
by Mahmoudpour, Seyed H
130 A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial.
by Mohan, Mohapradeep
131 The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.
by Bayes-Genis, Antoni
132 A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
by Voors, Adriaan A
133 The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach.
by Hoes, Martijn F
134 High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis.
by Chin, Calvin W L
135 Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).
by Hébert, Harry L
136 Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
by Ter Maaten, Jozine M
137 Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure.
by Ter Maaten, Jozine M
138 Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure.
by Kobayashi, Masatake
139 Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
by Emmens, Johanna E
140 Adverse prognosis associated with asymmetric myocardial thickening in aortic stenosis.
by Kwiecinski, Jacek